-
1 Comment
Bioanalytical Systems, Inc is currently in a long term uptrend where the price is trading 84.2% above its 200 day moving average.
From a valuation standpoint, the stock is 99.8% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 3.2.
Bioanalytical Systems, Inc's total revenue rose by 107.4% to $18M since the same quarter in the previous year.
Its net income has increased by 74.3% to $-366K since the same quarter in the previous year.
Finally, its free cash flow grew by 107.0% to $178K since the same quarter in the previous year.
Based on the above factors, Bioanalytical Systems, Inc gets an overall score of 5/5.
| Industry | Diagnostics & Research |
|---|---|
| Sector | Healthcare |
| Exchange | NASDAQ |
| CurrencyCode | USD |
| ISIN | US09058M1036 |
| PE Ratio | None |
|---|---|
| Target Price | 23 |
| Dividend Yield | 0.0% |
| Market Cap | 183M |
| Beta | 2.0 |
Bioanalytical Systems, Inc., doing business as Inotiv, provides drug discovery and development services to the pharmaceutical, chemical, and medical device industries; and sells analytical instruments to the pharmaceutical development and contract research industries. It operates through two segments, Contract Research Services and Research Products. The Contract Research Services segment offers screening and pharmacological testing, nonclinical safety testing, formulation development, regulatory compliance, and quality control testing services. This segment provides analytical method development and validation; drug metabolism, bioanalysis, and pharmacokinetics testing to identify and measure drug and metabolite concentrations in complex biological matrices; in vivo sampling services for the continuous monitoring of chemical changes in life; stability testing to ensure the integrity of various solutions used in nonclinical and clinical studies, and post-study analyses; non-clinical toxicology and pathology services; and climate-controlled archiving services for its customers' data and samples. The Research Products segment designs, develops, manufactures, and markets in vivo sampling systems and accessories, including disposables, training, and systems qualification; physiology monitoring tools; liquid chromatography and electrochemistry instruments platforms; analytical products comprising liquid chromatographic and electrochemical instruments with associated accessories; and in vivo sampling products consisting of Culex family of automated in vivo sampling and dosing instruments. The company operates in the United States, rest of North America, the Pacific Rim, Europe, and internationally. BioVaxys has an agreement with Inotiv to conduct preclinical toxicity studies for its Covid-T Immunodiagnostic program. Bioanalytical Systems, Inc. was founded in 1974 and is headquartered in West Lafayette, Indiana.
Learn MoreHere's how to backtest a trading strategy or backtest a portfolio for BASI using our backtest tool. PyInvesting provides the backtesting software for you to backtest your investment strategy. Our backtest software is written using Python code and allows you to backtest stock, backtest etf, backtest options, backtest crypto and backtest forex online. Our backtesting Python framework is highly robust and gives you a realistic simulation of how your strategy would have performed in the past using backtest data.
© PyInvesting 2025
